Skip to main content
Premium Trial:

Request an Annual Quote

All About the Narrative

MIT's Technology Review speaks with Knome's Jorge Conde about his company's $100,000 service, down from $350,000 when it launched in 2007. Conde doesn't say how many people Knome has sequenced but does note that 80 percent have been men in their mid-50s and that many customers are from outside the US. Sequencing is done at the Beijing Genomics Institute, then analyzed at Knome, and given to the customer on a USB drive during a day-long meeting. Knome has also recently partnered with Illumina to develop a more automated interpretation service to go along with Illumina's $48,000 sequencing service. "In the long-term, [analysis] will be a big driver of value," Conde says. "We will see the high price point go away, and the real value for both individuals and companies will be to provide an ongoing narrative."

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.